Provided by Tiger Trade Technology Pte. Ltd.

Boise Cascade

76.51
+0.25000.33%
Post-market: 76.510.00000.00%17:56 EST
Volume:647.22K
Turnover:49.65M
Market Cap:2.83B
PE:15.09
High:77.39
Open:76.76
Low:76.00
Close:76.26
52wk High:139.58
52wk Low:65.14
Shares:37.04M
Float Shares:36.95M
Volume Ratio:1.23
T/O Rate:1.75%
Dividend:0.85
Dividend Rate:1.11%
EPS(TTM):5.07
EPS(LYR):9.63
ROE:9.05%
ROA:4.75%
PB:1.32
PE(LYR):7.95

Loading ...

Boise Cascade Names Jeff Strom as Next CEO

Reuters
·
Dec 05

Boise Cascade Co - Jeff Strom Appointed as CEO Effective March 3, 2026

THOMSON REUTERS
·
Dec 05

Boise Cascade Co - Company Will Not Backfill COO Role After Transition

THOMSON REUTERS
·
Dec 05

Boise Cascade Announces CEO Transition

THOMSON REUTERS
·
Dec 05

BCC Fuba India Approves Plan to Acquire 51% Stake in Iogems Technologies

MT Newswires Live
·
Nov 28

Daiwabo to Take 21% Stake in BCC for 599 Million Yen

MT Newswires Live
·
Nov 27

Can Boise Cascade’s (BCC) Expansion Offset Industry Headwinds and Weak Earnings Guidance?

Simply Wall St.
·
Nov 25

Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers

GlobeNewswire
·
Nov 24

Boise Cascade (BCC): Exploring Current Valuation After Recent Share Price Decline

Simply Wall St.
·
Nov 21

Analysts Are Bullish on These Materials Stocks: American Resources (AREC), Boise Cascade (BCC)

TIPRANKS
·
Nov 21

Boise Cascade Is Maintained at Buy by DA Davidson

Dow Jones
·
Nov 21

Press Release: Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Dow Jones
·
Nov 20

Boise Cascade Q3 EPS USD 0.58

Reuters
·
Nov 20

Boise Cascade to acquire Holden Humphrey, financial terms not disclosed

TIPRANKS
·
Nov 18

BRIEF-Boise Cascade Reaches Agreement To Purchase Holden Humphrey

Reuters
·
Nov 18

Boise Cascade to Acquire Holden Humphrey in Northeast Expansion

Reuters
·
Nov 18

Boise Cascade Reaches Agreement to Purchase Holden Humphrey

THOMSON REUTERS
·
Nov 18

Andy Haldane: Budget speculation is hitting growth

cityam
·
Nov 17

Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 15

Jim Cramer: Don't Buy This Health Care Stock Yet, It Is 'Still Too Expensive'

Benzinga_recent_news
·
Nov 13